Breadcrumb Home Media centre Media releases Media Releases Quick Explore In the news Year 2022202120202019201820172016201520142013201220112010 Search News Apply Media Releases 2022 Cipla announces launch of leuprolide acetate injection depot (22.5mg) Cipla’s Indore plant joins the World Economic Forum’s (WEF) prestigious Lighthouse Network Cipla receives USFDA approval for generic version of Revlimid® (Lenalidomide Capsules) Cipla Health signs agreement to acquire Endura Mass Cipla to further invest in digital tech company GoApptiv to hold 22.02% stake post completion of proposed transaction Cipla signs agreement for acquisition of 21.05% stake in Achira Labs to develop affordable, innovative medical kits in India Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for young children living with HIV in South Africa Cipla adds capacity of captive renewable energy power plant in Maharashtra & Karnataka Cipla scored highest among pharma companies in CRISIL’s Sustainability Rating 2022 Cipla Launches 'RT Direct' Multiplex real time PCR kit for Covid-19 Cipla wins the prestigious Frost & Sullivan and TERI’s Sustainability 4.0 Award 2021 as “Challenger in Mega Large Business Pharma Sector”
